MedPath

Liver Fat Quantification by Magnetic Resonance Imaging (MRI) - Prediction of Postoperative Complications

Completed
Conditions
Fatty Liver
Surgery
Interventions
Other: Non-invasive Magnetic Resonance Imaging (MRI)
Procedure: Major liver resection
Registration Number
NCT01234714
Lead Sponsor
University of Zurich
Brief Summary

The purpose of this study is to objectively quantify liver fat content (LFC) by Magnetic Resonant Imaging (MRI) prior to major liver surgery, and to investigate its association with post-operative complications.

Detailed Description

Lack of agreement exists among expert pathologists in the standard histological assessment of hepatic steatosis on biopsy. The impact of different grades of steatosis on postoperative complications after major liver resection remains controversial.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
84
Inclusion Criteria
  • Major liver resection (>= 3 resected segments).
  • Patients that received a pre-operative Magnetic Resonance Imaging (MRI).
  • Patient over 18 years of age
Exclusion Criteria
  • Patients that underwent liver surgery but < 3 segments were resected (e.g. wedge liver resection).
  • Patient that did not receive a pre-operative MRI
  • Patient age less than 18 years of age.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Major liver resectionNon-invasive Magnetic Resonance Imaging (MRI)This single Cohort/Group will include all consecutive patients that received pre-operative Magnetic Resonant Imaging (MRI) and underwent major liver resection (\>=3 segments).
Major liver resectionMajor liver resectionThis single Cohort/Group will include all consecutive patients that received pre-operative Magnetic Resonant Imaging (MRI) and underwent major liver resection (\>=3 segments).
Primary Outcome Measures
NameTimeMethod
Percentage of Liver Fat Content on MRI in Patients With Serious Post-operative Complications (Clavien-Dindo Grade ≥IV)December 2010

Liver fat content, measured by MRI, uses the in-phase/out-of-phase imaging calculated in terms of fat signal fraction (FSF).

The Clavien-Dindo Classification of Surgical Complications:

Grade I: Any deviation from the normal postoperative course without the need for treatment. Grade II: Requiring pharmacological treatment with drugs. Grade III: Requiring surgical, endoscopic or radiological intervention. Grade IV: Life-threatening complication requiring IC/ICU-management. Grade V: Death of a patient

Secondary Outcome Measures
NameTimeMethod
Post-operative Alanine Transaminase (ALT) LevelsDecember 2010

Alanine Transaminase is commonly measured clinically as a part of a diagnostic evaluation of hepatocellular injury, to determine liver health.

Intra-operative Blood LossDecember 2010

Intra-operative blood loss was defined according to the total volume of blood loss from the beginning until the end of the operation.

Operative TimeDecember 2010

The operation duration was measured according to the total minutes from the beginning of the operation until the end.

Intensive Care Unit (ICU) StayDecember 2010

The Intensive Care Unit (ICU) stay was calculated according to the total number of days the patients were managed in the ICU. This included also multiple ICU admissions.

Hospital StayDecember 2010

The patient hospital stay was calculated according to the total number of days the patient was hospitalized.

CostDecember 2010

The total in-hospital costs were calculated for each patient in Euros.

Type of Post-operative ComplicationsDecember 2010

There are several different types of post-operative complications associated with liver surgery, such as liver failure, multi-organ failure, bleeding, bile leak, and sepsis.

Trial Locations

Locations (2)

University Hospital Zurich, Department of Interventional and Diagnostic Radiology

🇨🇭

Zurich, Switzerland

University Hospital Zurich, Department of Visceral and Transplant Surgery, Swiss Hepato-Pancreato-Biliary (HPB) Center

🇨🇭

Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath